By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Investment markets and key developments US and ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

The sale represents Clever Culture’s fifth engagement with a leading pharma manufacturer, including AstraZeneca, Bristol Myers Squibb and Thermo Fisher. The company is due to report its Q4 FY25 ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Ultimately, the TACO trade may be coming to a close and will be a fun meme for us to remember. This time, I think tariffs ...

President Donald Trump says he plans to place tariffs of over 10% on smaller countries, including nations in Africa and the ...